More Videos
SPECIAL REPORT
MOST SHARED
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Citi Mortgage Reveals What Treasury Won't
- NBA D-League On The Rise
- Wednesday's Economic News Crunch Could Tilt Markets
- Japan Export Rebound Eases Fear of New Recession
- Australia Wheat Exporters Face Challenges: GrainCorp
- Trading Block
- Confessions of a Black Friday Shopper
- The Social Media Gaming Threat
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- Amended Berkshire Filing Reveals No 'Secret' Holdings
- In Time for Holidays: More Gloom and Doom on Economy
- Holiday Guide to This Season's Smartphones
- Market Pros Reveal Top Black Friday Trades
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
Text Size 
 |
]) It was responsible for a penny of the earnings miss. On "Squawk Box" that morning CEO Jeff Immelt said the longer-than-expected closure of a manufacturing plant was partially to blame.
Then, later on the conference call, officials said toward the end of the quarter orders from community hospitals fell 18 percent. That translated, they said, into $100 million of lost revenue.
JPMorgan Chase medical device analyst Mike Weinstein tipped me off that the GE healthcare weakness was having an immediate ripple effect on a whole basket of stocks in companies that also make big-ticket items for hospitals. (GE makes expensive equipment like CT scanners.)
What made the story even more interesting is that it could be traced back to the spreading credit crisis. Not-for-profit hospitals suddenly are having to pay a much higher interest rate on their debt financing and so they're chopping their capital expenditures.
According to Dr. Christopher Olivia, who runs a six-hospital system in western Pennsylvania, many municipal and religious-based facilities have seen their rates triple or more almost overnight. (Video clip is from Friday.)
But in a research note to clients this morning Miller-Tabak healthcare analyst Les Funtleyder is incredulous. He says, "While it is obvious we are in the midst of a negative credit cycle which should impact med tech to some degree, this should have been discounted already and we find it surprising the GE would be the canary in the coal mine on this."
Funtleyder adds, "We are skeptical about the reduction in capital spending until we see the actual reduction."
But JPMorgan's Weinstein tells me the downturn is still out in front of the companies whose stocks got taken down Friday on the GE report. He believes that for most of them the hospital capex cuts could be more of a second quarter than first quarter issue.
We'll know soon enough.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes